Your browser doesn't support javascript.
loading
Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.
Purrington, Kristen S; Visscher, Daniel W; Wang, Chen; Yannoukakos, Drakoulis; Hamann, Ute; Nevanlinna, Heli; Cox, Angela; Giles, Graham G; Eckel-Passow, Jeanette E; Lakis, Sotiris; Kotoula, Vassiliki; Fountzilas, George; Kabisch, Maria; Rüdiger, Thomas; Heikkilä, Päivi; Blomqvist, Carl; Cross, Simon S; Southey, Melissa C; Olson, Janet E; Gilbert, Judy; Deming-Halverson, Sandra; Kosma, Veli-Matti; Clarke, Christine; Scott, Rodney; Jones, J Louise; Zheng, Wei; Mannermaa, Arto; Eccles, Diana M; Vachon, Celine M; Couch, Fergus J.
Afiliação
  • Purrington KS; Department of Oncology, Wayne State University School of Medicine and Karmanos Cancer Institute, Detroit, USA.
  • Visscher DW; Department of Health Sciences Research, Mayo Clinic, Stabile 2-42, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
  • Wang C; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA.
  • Yannoukakos D; Department of Health Sciences Research, Mayo Clinic, Stabile 2-42, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
  • Hamann U; Molecular Diagnostics Laboratory INRASTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
  • Nevanlinna H; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cox A; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
  • Giles GG; Department of Oncology, University of Sheffield, Sheffield, UK.
  • Eckel-Passow JE; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia.
  • Lakis S; Department of Health Sciences Research, Mayo Clinic, Stabile 2-42, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
  • Kotoula V; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
  • Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
  • Kabisch M; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
  • Rüdiger T; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Heikkilä P; Institute of Pathology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  • Blomqvist C; Department of Pathology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
  • Cross SS; Department of Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
  • Southey MC; Department of Neuroscience, University of Sheffield, Sheffield, UK.
  • Olson JE; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia.
  • Gilbert J; Department of Health Sciences Research, Mayo Clinic, Stabile 2-42, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
  • Deming-Halverson S; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA.
  • Kosma VM; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, USA.
  • Clarke C; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
  • Scott R; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
  • Jones JL; Centre for Cancer Research, University of Sydney at the Westmead Millennium Institute, Westmead, Australia.
  • Zheng W; Division of Genetics, Hunter Area Pathology Service and University of Newcastle, Newcastle, Australia.
  • Mannermaa A; Barts Cancer Research Institute, Queen Mary University of London, London, UK.
  • Eccles DM; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
  • Vachon CM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
Breast Cancer Res Treat ; 157(1): 117-31, 2016 05.
Article em En | MEDLINE | ID: mdl-27083182
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise de Sequência de RNA / Perfilação da Expressão Gênica / Redes Reguladoras de Genes / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise de Sequência de RNA / Perfilação da Expressão Gênica / Redes Reguladoras de Genes / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Holanda